Harrow Health, Inc. logo HROW - Harrow Health, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 10
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $73.67 DETAILS
HIGH: $88.00
LOW: $63.00
MEDIAN: $70.00
CONSENSUS: $73.67
UPSIDE: 123.24%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Revenue
Revenue 272.3 199.6 130.2 88.6 72.5 48.9 51.2 41.4 26.8 19.9 9.7 1.7 0.0 0.1 0 0 0 0 0 0 0
Cost of Revenue 67.9 49.2 39.6 25.4 18.2 14.5 16.7 16.5 13.5 9.8 5.2 1.1 0 0 0 0 0.0 0 0 0 0.4
Gross Profit 204.4 150.4 90.6 63.2 54.3 34.4 34.4 24.9 13.3 10.1 4.5 0.6 0.0 0.1 0 0 0 0 0 0 (0.4)
Operating Expenses
R&D Expenses 12.8 12.2 6.7 3.0 11.1 2.4 2.1 0.8 0.4 0.7 0.3 0.2 1.6 1.3 0.1 0.2 3.0 2.0 1.8 0.1 0
SG&A Expenses 152.9 0 0 0 39.8 0 33.1 29.2 25.0 25.0 19 10.5 6.1 3.0 0.8 2.3 1.6 1.8 2.9 0.0 0.1
Other Expenses 0 129.3 83.5 58.2 1.7 31.6 4.0 0.1 0 0 0.0 0 0 0 0 0 0 0 0 (0.1) 0
Operating Expenses 165.8 141.5 90.1 61.3 52.6 34.0 39.2 30.1 25.4 25.7 19.3 10.7 7.7 4.3 0.9 2.5 4.6 3.7 2.9 0.0 0.1
Operating Income
Operating Income 38.6 8.8 0.4 1.9 1.6 0.4 (4.8) (5.2) (12.2) (15.9) (14.8) (10.1) (7.7) (4.2) (0.9) (2.5) (4.6) (3.7) (2.9) (0.0) (0.5)
Interest Expense 24.2 22.8 21.3 7.2 5.4 2.2 2.5 2.7 3.0 2.8 1.1 0.0 0 0.0 0.1 0.1 0 0 1.6 (0.0) 0.0
Interest Income 0 0 0 0 0 0 0 0 0 0.0 0.0 0.0 0.0 0.0 0 0.0 0.0 0.1 0.0 0 0
Profitability
EBITDA 57.5 22.1 11.9 4.8 5.1 2.6 1.9 (3.4) (10.4) (14.2) (14.2) (10.1) (7.6) (5.4) (0.9) (2.5) (4.6) (4.1) (2.7) (0.0) (0.5)
EBIT 38.6 9.1 0.8 1.9 3.4 0.7 (0.7) (5.2) (12.2) (15.5) (14.8) (10.1) (7.6) (5.4) (0.9) (2.5) (4.6) (3.3) (2.7) (0.6) (0.5)
Income Before Tax (1.7) (17.3) (23.7) (14.0) (17.9) (3.4) (0.1) 14.6 (12.9) (19.2) (15.9) (10.1) (7.6) (5.4) (1.0) (2.5) (4.6) (3.4) (4.3) (0.6) (0.5)
Income Tax Expense 3.4 0.2 0.7 0.1 0.1 0.0 0.0 0 (0.9) (0.1) 0 (0.0) (0.0) 0 0 0 (0.0) (0.8) 0 0.0 0
Net Income (5.1) (17.5) (24.4) (14.1) (18.0) (3.4) 0.2 14.6 (12.0) (19.1) (15.9) (10.1) (7.6) (5.4) (1.0) (2.5) (4.6) (3.3) (4.3) (0.0) (0.5)
Per Share Data
EPS (Basic) -0.14 -0.49 -0.75 -0.51 -0.69 -0.13 0.01 0.67 -0.60 -1.50 -1.66 -1.11 -0.88 -1.24 -2.40 -6.41 -11.67 -8.92 -19.37 -0.25 -0.04
EPS (Diluted) -0.14 -0.49 -0.75 -0.51 -0.69 -0.13 0.01 0.61 -0.60 -1.50 -1.66 -1.11 -0.88 -1.24 -2.40 -6.41 -11.67 -8.92 -19.37 -0.25 -0.04
Shares Outstanding 36.8 35.7 32.6 27.5 26.8 25.9 25.3 21.9 20.0 12.7 9.6 9.1 8.7 4.5 0.4 0.4 0.4 0.4 0.2 0.2 12.2
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008
Current Assets
Cash & Cash Equivalents 72.9 47.2 74.1 96.3 42.2 4.1 4.7 6.6 4.0 8.9 1.6 5.1
Short-Term Investments 0 0 8.7 5.6 8.5 28.6 25.2 21.4 0 0 0 0
Net Receivables 110.9 116.6 36.5 6.4 4.5 2.7 2.0 2.0 1.6 2.9 0 0
Inventory 13.5 10.7 10.9 6.5 4.2 4.0 3.3 1.8 2.2 1.8 0 0
Other Current Assets 14.4 3.4 1.8 0.1 0.1 1.1 0.9 0.1 0.1 0.2 0 0
Total Current Assets 211.8 189.7 139.1 118.3 60.7 41.0 36.8 32.8 8.8 14.8 1.7 5.3
Non-Current Assets
Property, Plant & Equipment 11.0 12.3 12.4 11.0 9.1 10.7 11.9 6.4 6.2 7.3 0.0 0.0
Goodwill 0.3 0.3 0.3 0.3 0.3 0.3 0.3 2.2 2.2 2.2 0 0
Intangible Assets 175.2 186.7 159.9 25.8 17.1 2.5 2.3 3.1 2.9 3.0 0 0
Long-Term Investments 0 0 0 0 11.1 3.0 7.7 4.9 3.5 0 0 0
Other Non-Current Assets 1.2 0 0 1.9 12.4 0 7.7 4.9 0.3 0 0 0
Total Non-Current Assets 187.7 199.3 172.7 39.1 37.7 16.5 22.3 16.6 15.1 12.5 0.0 0.0
Total Assets 399.5 389.0 311.8 157.4 98.3 57.5 59.1 49.5 23.9 27.2 1.7 5.3
Current Liabilities
Account Payables 35.4 38.8 21.4 6.4 5.2 3.6 7.4 5.0 3.9 3.5 0.7 0.6
Short-Term Debt 0.9 0 0.8 0 0 3.9 1.8 3.2 0.6 4.4 0 0
Deferred Revenue 0.8 0.0 0 0.1 0.0 0 0.1 0.1 0.0 0.1 0 0
Other Current Liabilities 59.3 0 21.7 0 1.2 0.1 0.3 0.6 (0.5) (0.3) 0 0
Total Current Liabilities 96.3 91.3 49.3 18.6 9.7 10.8 12.3 11.9 5.8 9.9 1.1 0.8
Non-Current Liabilities
Long-Term Debt 243.2 219.5 183.2 104.2 71.7 12.4 12.2 12.0 14.0 7.9 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0.9 0 0
Other Non-Current Liabilities 0 0 2.7 0 0 0.8 0.8 0.8 0.8 0.7 0 0
Total Non-Current Liabilities 251.1 228.3 192.4 111.5 77.7 19.8 19.4 12.8 15.5 10.9 0 0
Total Liabilities 347.4 319.7 241.8 130.1 87.4 30.6 31.7 24.7 21.3 20.8 1.1 0.8
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (156.5) (151.4) (133.9) (109.5) (95.4) (77.4) (74.0) (74.2) (88.8) (76.9) (14.9) (10.4)
Accumulated Other Comprehensive Income 0 0 (0.4) 0 0 0 0 (4.4) (2.8) (1.4) 0 0
Total Stockholders' Equity 52.4 69.7 70.4 27.6 11.3 27.2 27.7 24.8 2.6 6.4 0.6 4.6
Total Liabilities & Equity 399.5 389.0 311.8 157.4 98.3 57.5 59.1 49.5 23.9 27.2 1.7 5.3
Debt Metrics
Total Debt 252.0 228.8 190.5 112.2 78.0 23.5 21.0 15.2 15.3 13.7 0 0
Net Debt 179.0 181.6 116.4 16.0 35.8 19.4 16.2 8.6 11.3 4.8 (1.6) (5.1)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income (5.1) (17.5) (24.4) (14.1) (18.0) (3.4) (0.1) 14.6 (12.0) (19.1)
Depreciation & Amortization 19.7 14.5 12.3 3.7 2.4 2.7 2.7 1.8 1.8 1.4
Stock-Based Compensation 12.5 17.6 15.7 8.0 5.7 2.8 2.0 2.6 2.9 3.7
Change in Working Capital 0.2 (44.6) (7.1) (5.6) (0.3) (6.3) (1.7) 3.4 0.7 (0.7)
Other Non-Cash Items 16.6 7.7 7.3 9.7 15.2 3.1 0.5 0.6 (1.3) 3.6
Operating Cash Flow 43.9 (22.2) 3.8 1.7 5.1 (1.1) 0.9 0.7 (8.8) (11.2)
Investing Activities
Capital Expenditure (0.9) (38.7) (152.6) (7.8) (28.5) (1.0) (1.8) (2.2) (1.1) (7.1)
Acquisitions (4.4) 0 0 0 9.8 0 0.0 0 0.1 (0.1)
Purchases of Investments 0 0 0 0 0 0 0 0 0 (0.1)
Sales/Maturities of Investments 0 5.5 0 0 9.8 0 0 0 0 0
Other Investing Activities 0 (37.1) (151.1) 0.9 (36.6) (0.1) 0 0.0 0.1 (0.1)
Investing Cash Flow (5.5) (33.2) (152.6) (1.7) (18.7) (1.0) (1.8) (2.2) (1.0) (7.3)
Financing Activities
Net Debt Issuance 11.8 29.8 74.6 31.7 71.1 3.0 (1.5) (0.7) 0.9 (0.3)
Stock Repurchased 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 (0.1) 0 0 0 0 0
Other Financing Activities (25.0) (1.3) (12.6) (0.2) (19.1) (1.5) (0.3) 4.2 (0.0) 4.4
Financing Cash Flow (12.7) 28.5 126.5 54.1 51.5 1.4 (1.0) 4.1 4.9 24.7
Cash Position
Net Change in Cash 25.7 (26.8) (22.2) 54.1 37.9 (0.6) (1.9) 2.6 (4.8) 6.2
Cash at Beginning 47.2 74.1 96.3 42.2 4.3 4.9 6.8 4.2 8.9 2.7
Cash at End 72.9 47.2 74.1 96.3 42.2 4.3 4.9 6.8 4.0 8.9
Free Cash Flow 43.0 (60.9) (148.7) (6.1) (23.4) (2.1) (0.9) (1.5) (9.9) (18.4)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
Income Statement
Revenue 272.3 199.6 130.2 88.6 72.5 48.9 51.2 41.4 26.8 19.9 9.7 1.7 0.0 0.1 0 0 0 0 0 0 0
Gross Profit 204.4 150.4 90.6 63.2 54.3 34.4 34.4 24.9 13.3 10.1 4.5 0.6 0.0 0.1 0 0 0 0 0 0 (0.4)
Operating Income 38.6 8.8 0.4 1.9 1.6 0.4 (4.8) (5.2) (12.2) (15.9) (14.8) (10.1) (7.7) (4.2) (0.9) (2.5) (4.6) (3.7) (2.9) (0.0) (0.5)
Net Income (5.1) (17.5) (24.4) (14.1) (18.0) (3.4) 0.2 14.6 (12.0) (19.1) (15.9) (10.1) (7.6) (5.4) (1.0) (2.5) (4.6) (3.3) (4.3) (0.0) (0.5)
EPS (Diluted) -0.14 -0.49 -0.75 -0.51 -0.69 -0.13 0.01 0.61 -0.60 -1.50 -1.66 -1.11 -0.88 -1.24 -2.40 -6.41 -11.67 -8.92 -19.37 -0.25 -0.04
Balance Sheet
Cash & Equivalents 72.9 47.2 74.1 96.3 42.2 4.1 4.7 6.6 4.0 8.9 1.6 5.1
Total Assets 399.5 389.0 311.8 157.4 98.3 57.5 59.1 49.5 23.9 27.2 1.7 5.3
Total Debt 252.0 228.8 190.5 112.2 78.0 23.5 21.0 15.2 15.3 13.7 0 0
Stockholders' Equity 52.4 69.7 70.4 27.6 11.3 27.2 27.7 24.8 2.6 6.4 0.6 4.6
Cash Flow
Operating Cash Flow 43.9 (22.2) 3.8 1.7 5.1 (1.1) 0.9 0.7 (8.8) (11.2)
Capital Expenditure (0.9) (38.7) (152.6) (7.8) (28.5) (1.0) (1.8) (2.2) (1.1) (7.1)
Free Cash Flow 43.0 (60.9) (148.7) (6.1) (23.4) (2.1) (0.9) (1.5) (9.9) (18.4)